Krebs Stimulator Plus

Product NDC: 57520-0217
11-digit product format: 575200217
Labeler code: 57520
Product ID: 57520-0217_10514191-5382-4ba8-9694-40ccf8e16760
Type: HUMAN OTC DRUG
Nonproprietary name: Tabebuia impetiginosa, Uncaria tomentosa, Hypothalamus, Pituitary, Glandula suprarenalis, Nadidum, Lacticum acidum,
Dosage form: LIQUID
Route: ORAL
Labeler: Apotheca Company
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2010-03-25
Marketing end: 0000-00-00
Substance: TABEBUIA IMPETIGINOSA BARK; CAT'S CLAW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; SUS SCROFA ADRENAL GLAND; NADIDE; LACTIC ACID, DL-; LACTIC ACID, L-; COENZYME A; ADENOSINE TRIPHOSPHATE; BIS(CARBOXYETHYL)GERMANIUM SESQUIOXIDE; UBIDECARENONE
Active strength: 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	57520-0217		I	Inactivated by FDA		2026-08-17
excluded package	package	57520-0217	57520-0217-1	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	57520-0217-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	57520-0217-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	57520-0217-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	57520-0217-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	57520-0217-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	57520-0217-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	57520-0217-1	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	57520-0217-1	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	57520-0217-1	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	57520-0217-1	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	57520-0217-1	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	57520-0217-1	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	57520-0217-1	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	57520-0217-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	57520-0217-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	57520-0217-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	57520-0217-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	57520-0217-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	57520-0217-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	57520-0217-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	57520-0217-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	57520-0217-1	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
57520-0217-1	2020-01-31	C162847	48780-1	9d75b9d0-7c81-f424-e053-dadaa90a57ce	Krebs Stimulator Plus

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
57520-0217-1	Krebs Stimulator Plus	60 mL in 1 BOTTLE, DROPPER	LIQUID	60		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ADENOSINE TRIPHOSPHATE	ACTIVE INGREDIENT	8L70Q75FXE	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
BIS(CARBOXYETHYL)GERMANIUM SESQUIOXIDE	ACTIVE INGREDIENT	96WE91N25T	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
CAT'S CLAW	ACTIVE INGREDIENT	9060PRM18Q	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
COENZYME A	ACTIVE INGREDIENT	SAA04E81UX	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
LACTIC ACID, DL-	ACTIVE INGREDIENT	3B8D35Y7S4	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
LACTIC ACID, L-	ACTIVE INGREDIENT	F9S9FFU82N	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
NADIDE	ACTIVE INGREDIENT	0U46U6E8UK	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
SUS SCROFA ADRENAL GLAND	ACTIVE INGREDIENT	398IYQ16YV	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
SUS SCROFA HYPOTHALAMUS	ACTIVE INGREDIENT	N6R0856Z79	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
SUS SCROFA PITUITARY GLAND	ACTIVE INGREDIENT	E8S87O660T	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
TABEBUIA IMPETIGINOSA BARK	ACTIVE INGREDIENT	6GLA1946WX	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
UBIDECARENONE	ACTIVE INGREDIENT	EJ27X76M46	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
ADENOSINE TRIPHOSPHATE	ACTIVE MOIETY	8L70Q75FXE	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
BIS(CARBOXYETHYL)GERMANIUM SESQUIOXIDE	ACTIVE MOIETY	96WE91N25T	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
CAT'S CLAW	ACTIVE MOIETY	9060PRM18Q	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
COENZYME A	ACTIVE MOIETY	SAA04E81UX	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
LACTIC ACID, DL-	ACTIVE MOIETY	3B8D35Y7S4	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
LACTIC ACID, L-	ACTIVE MOIETY	F9S9FFU82N	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
NADIDE	ACTIVE MOIETY	0U46U6E8UK	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
SUS SCROFA ADRENAL GLAND	ACTIVE MOIETY	398IYQ16YV	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
SUS SCROFA HYPOTHALAMUS	ACTIVE MOIETY	N6R0856Z79	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
SUS SCROFA PITUITARY GLAND	ACTIVE MOIETY	E8S87O660T	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
TABEBUIA IMPETIGINOSA BARK	ACTIVE MOIETY	6GLA1946WX	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
UBIDECARENONE	ACTIVE MOIETY	EJ27X76M46	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
57520-0217	KREBS STIMULATOR PLUS (TABEBUIA IMPETIGINOSA, UNCARIA TOMENTOSA, HYPOTHALAMUS, PITUITARY, GLANDULA SUPRARENALIS, NADIDUM, LACTICUM ACIDUM,) LIQUID [APOTHECA COMPANY]	1	Legacy NDC, 1 package rows	20100720_94a21b5a-a543-4cf4-9b60-cadb70f0bcbd.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9060PRM18Q	CAT'S CLAW		CAT'S CLAW
N6R0856Z79	SUS SCROFA HYPOTHALAMUS		SUS SCROFA HYPOTHALAMUS
L0PFEMQ1DT	SUS SCROFA PITUITARY GLAND		SUS SCROFA PITUITARY GLAND
398IYQ16YV	SUS SCROFA ADRENAL GLAND		SUS SCROFA ADRENAL GLAND
0U46U6E8UK	NADIDE	53-84-9	NADIDE
3B8D35Y7S4	LACTIC ACID, DL-	50-21-5	LACTIC ACID, DL-
F9S9FFU82N	LACTIC ACID, L-	79-33-4	LACTIC ACID, L-
SAA04E81UX	COENZYME A	85-61-0	COENZYME A
8L70Q75FXE	ADENOSINE TRIPHOSPHATE	56-65-5	ADENOSINE TRIPHOSPHATE
EJ27X76M46	UBIDECARENONE	303-98-0	UBIDECARENONE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
57520-0217-1	57520021701	60 mL in 1 BOTTLE, DROPPER	60 ml	Historical